or Try an Advanced Search...

    Technical Analysis for ARQT - Arcutis Biotherapeutics, Inc.

    Grade Last Price % Change Price Change
    B 9.18 -2.86% -0.27
    ARQT closed down 7.8 percent on Thursday, April 18, 2024, on 69 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: May 7
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical ARQT trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish -2.86%
    180 Bearish Setup Bearish Swing Setup -2.86%
    Stochastic Reached Oversold Weakness -2.86%
    Multiple of Ten Bearish Other -2.86%
    Outside Day Range Expansion -2.86%
    Wide Bands Range Expansion -2.86%
    Oversold Stochastic Weakness -2.86%
    NR7 Range Contraction -10.44%
    Narrow Range Bar Range Contraction -10.44%
    Multiple of Ten Bullish Other -10.44%
    Older End-of-Day Signals for ARQT ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 2 hours ago
    Down 3% about 2 hours ago
    Bearish 180 Entry about 2 hours ago
    Fell Below Previous Day's Low about 2 hours ago
    Down 2 % about 2 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ARQT Chart by TradingView
    Basic chart:

    Profile

    Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Immunology Organ Systems Autoimmune Disease Psoriasis Atopic Dermatitis Dermatitis Type I Hypersensitivity Atopy Eczema Alopecia Areata Dermatological Diseases Plaque Psoriasis Vitiligo

    Is ARQT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 10 Arcutis Biotherapeutics appoints CFO
    Apr 10 Arcutis Appoints David Topper as Chief Financial Officer
    Apr 8 Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?
    Apr 5 Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Apr 1 Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
    Mar 28 Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference
    Mar 19 Arcutis Biotherapeutics, Inc. (ARQT) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
    Mar 19 Is Adverum Biotechnologies (ADVM) Stock Outpacing Its Medical Peers This Year?
    Mar 18 Wall Street Analysts See a 54.78% Upside in Arcutis Biotherapeutics, Inc. (ARQT): Can the Stock Really Move This High?
    Mar 11 EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
    See more ARQT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 15.21
    52 Week Low 1.76
    Average Volume 4,258,794
    200-Day Moving Average 6.52
    50-Day Moving Average 9.85
    20-Day Moving Average 10.40
    10-Day Moving Average 11.07
    Average True Range 0.91
    RSI (14) 43.18
    ADX 25.47
    +DI 24.29
    -DI 29.89
    Chandelier Exit (Long, 3 ATRs) 10.45
    Chandelier Exit (Short, 3 ATRs) 11.81
    Upper Bollinger Bands 12.55
    Lower Bollinger Band 8.24
    Percent B (%b) 0.28
    BandWidth 41.50
    MACD Line 0.17
    MACD Signal Line 0.39
    MACD Histogram -0.2203
    Fundamentals Value
    Market Cap 914.69 Million
    Num Shares 96.8 Million
    EPS -4.33
    Price-to-Earnings (P/E) Ratio -2.18
    Price-to-Sales 13.14
    Price-to-Book 13.63
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 11.06
    Resistance 3 (R3) 11.19 10.78 10.79
    Resistance 2 (R2) 10.78 10.37 10.72 10.70
    Resistance 1 (R1) 10.12 10.12 9.92 9.99 10.61
    Pivot Point 9.71 9.71 9.61 9.65 9.71
    Support 1 (S1) 9.05 9.30 8.85 8.92 8.29
    Support 2 (S2) 8.64 9.05 8.58 8.20
    Support 3 (S3) 7.98 8.64 8.11
    Support 4 (S4) 7.85